Skip to main content
Clinical Trials/NL-OMON43328
NL-OMON43328Not yet recruitingNot Applicable

Hormonal changes in aggressive behavior, an idiographic study - Hormonal changes in aggressive behaviour

Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites6 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
6

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • The following participants will be included to the study:
  • - Participants without any psychiatric disorder. These will be participants who are confronted with aggressive behaviour in their professional daily life, but do not initiate this behaviour (e.g. mental health nurse, policeman).
  • - Psychotic patients, who have florid psychotic symptoms. They have an axis-I diagnosis of schizophrenia, according to the DSM IV criteria (American Psychiatric Association, 2000) as assessed by a psychiatrist. They have no axis-II diagnosis.
  • - Antisocial personality disordered patients; according to the DSM IV criteria (American Psychiatric Association, 2000) as assessed by a psychiatrist. They have no axis-I diagnosis and have a PCL-r score <26.
  • - Anti-social personality disordered patients, according to the DSM IV criteria (American Psychiatric Association, 2000) as assessed by a psychiatrist. They have no axis-I diagnosis and a PCL-r score >26.;In this study, only male participants are included, as it is thought that the hormonal fluctuations in the female reproductive cycle might interact with all our hormonal parameters, especially with the oxytocin levels. Apart from that, the majority of patients treated in the Dutch *TBS* clinics is male.

Exclusion Criteria

  • Participants who are not able to fulfil the intensive measurements because of their severe psychiatric symptoms will be excluded. To determine whether a patient is able to participate in the study, the psychiatrist who treats the patient will be consulted.

Investigators

Similar Trials